World's First! BRL Medicin's BCMA UCAR-T Successfully Treats Neuromyelitis Optica Spectrum Disorder
2025-10-11
The First Patient Treated with BRL Medicine’s BRL-201 Therapy Achieves Over 5 Years of Cancer-Free Survival
2025-09-17
World's First! BRL Medicine's UCAR-T Successfully Treat Relapsed/Refractory Systemic Lupus Erythematosus
2025-05-13
BRL Medicine Team Publishes Groundbreaking Review in Cancer Cell: CAR-T Therapy for Solid Tumors
2025-04-18
BRL Medicine Non viral Targeted Integration PD1-CAR-T Therapy for Lupus Erythematosus Approved by China IND
2024-11-05
Nature Chemical Biology! BRL medicine team developed a highly accurate and efficient cytosine base editor
2024-04-02